Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction

BACKGROUND: Soluble suppression of tumorigenicity 2 (sST2) receptor is a biomarker that is elevated in certain systemic inflammatory diseases. Comorbidity‐driven microvascular inflammation is postulated to play a key role in heart failure with preserved ejection fraction (HFpEF) pathophysiology, but...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Am Heart Assoc
Main Authors: AbouEzzeddine, Omar F., McKie, Paul M., Dunlay, Shannon M., Stevens, Susanna R., Felker, G. Michael, Borlaug, Barry A., Chen, Horng H., Tracy, Russell P., Braunwald, Eugene, Redfield, Margaret M.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523750/
https://ncbi.nlm.nih.gov/pubmed/28214792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.004382
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki